{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:16:06Z","timestamp":1781554566339,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["21-75-30015"],"award-info":[{"award-number":["21-75-30015"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-025-00477-5","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T11:28:30Z","timestamp":1748258910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["5\u2019UTR gene regions in germline DNA sequencing panels: lessons from the analysis of breast and ovarian cancer patients of Tatar and Bashkir ethnic origin"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6304-1609","authenticated-orcid":false,"given":"Anna P.","family":"Sokolenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6504-8636","authenticated-orcid":false,"given":"Aigul R.","family":"Venina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6549-8378","authenticated-orcid":false,"given":"Alexandr A.","family":"Romanko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2658-3860","authenticated-orcid":false,"given":"Evgenia V.","family":"Belogubova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr V.","family":"Sultanbayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0988-7261","authenticated-orcid":false,"given":"Vadim E.","family":"Askarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5913-1051","authenticated-orcid":false,"given":"Gulnara K.","family":"Mukhamediarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7800-013X","authenticated-orcid":false,"given":"Elvina Kh.","family":"Bakaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Syomina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana Yu.","family":"Velyukhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Preobrazhenskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3830-8364","authenticated-orcid":false,"given":"Alexandr V.","family":"Togo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-7891","authenticated-orcid":false,"given":"Evgeny N.","family":"Imyanitov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"477_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/humu.23406","volume":"39","author":"TR Rebbeck","year":"2018","unstructured":"Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, Olah E, Olopade OI, Solano AR, Teo SH et al (2018) Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat 39:593\u2013620. https:\/\/doi.org\/10.1002\/humu.23406","journal-title":"Hum Mutat"},{"key":"477_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10549-010-1290-4","volume":"126","author":"N Bogdanova","year":"2011","unstructured":"Bogdanova N, Sokolenko AP, Iyevleva AG, Abysheva SN, Blaut M, Bremer M, Christiansen H, Rave-Fr\u00e4nk M, D\u00f6rk T, Imyanitov E (2011) PALB2 mutations in German and Russian patients with bilateral breast cancer. Breast Cancer Res Treat 126:545\u2013550. https:\/\/doi.org\/10.1007\/s10549-010-1290-4","journal-title":"Breast Cancer Res Treat"},{"key":"477_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1399-0004.2011.01824.x","volume":"82","author":"D Prokofyeva","year":"2012","unstructured":"Prokofyeva D, Bogdanova N, Bermisheva M, Zinnatullina G, Hillemanns P, Khusnutdinova E, D\u00f6rk T (2012) Rare occurrence of PALB2 mutations in ovarian cancer patients from the Volga-Ural region. Clin Genet 82:100\u2013101. https:\/\/doi.org\/10.1111\/j.1399-0004.2011.01824.x","journal-title":"Clin Genet"},{"key":"477_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylk\u00e4s K, Roberts J, Lee A, Subramanian D, De Leeneer K, Fostira F et al (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371:497\u2013506. https:\/\/doi.org\/10.1056\/NEJMoa1400382","journal-title":"N Engl J Med"},{"key":"477_CR5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1200\/JCO.19.01907","volume":"38","author":"X Yang","year":"2020","unstructured":"Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I et al (2020) Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families. J Clin Oncol 38:674\u2013685. https:\/\/doi.org\/10.1200\/JCO.19.01907","journal-title":"J Clin Oncol"},{"key":"477_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ijc.33317","volume":"148","author":"EV Preobrazhenskaya","year":"2021","unstructured":"Preobrazhenskaya EV, Shleykina AU, Gorustovich OA, Martianov AS, Bizin IV, Anisimova EI, Sokolova TN, Chuinyshena SA, Kuligina ES, Togo AV, Belyaev AM, Ivantsov AO, Sokolenko AP, Imyanitov EN (2021) Frequency and molecular characteristics of PALB2-associated cancers in Russian patients. Int J Cancer 148:203\u2013210. https:\/\/doi.org\/10.1002\/ijc.33317","journal-title":"Int J Cancer"},{"key":"477_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ygyno.2023.07.017","volume":"177","author":"P Narayan","year":"2023","unstructured":"Narayan P, Ahsan MD, Webster EM, Perez L, Levi SR, Harvey B, Wolfe I, Beaumont S, Brewer JT, Siegel D et al (2023) Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis. Gynecol Oncol 177:72\u201385. https:\/\/doi.org\/10.1016\/j.ygyno.2023.07.017","journal-title":"Gynecol Oncol"},{"key":"477_CR8","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1158\/0008-5472.CAN-09-0851","volume":"70","author":"J Mouchawar","year":"2010","unstructured":"Mouchawar J, Korch C, Byers T, Pitts TM, Li E, McCredie MR, Giles GG, Hopper JL, Southey MC (2010) Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian breast Cancer family study. Cancer Res 70:4795\u20134800. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-0851","journal-title":"Cancer Res"},{"key":"477_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12282-020-01151-7","volume":"28","author":"E Rogo\u017ca-Janiszewska","year":"2021","unstructured":"Rogo\u017ca-Janiszewska E, Mali\u0144ska K, G\u00f3rski B, Scott RJ, Cybulski C, Klu\u017aniak W, Lener M, Jakubowska A, Gronwald J, Huzarski T, Lubi\u0144ski J, D\u0119bniak T (2021) Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population. Breast Cancer 28:226\u2013235. https:\/\/doi.org\/10.1007\/s12282-020-01151-7","journal-title":"Breast Cancer"},{"key":"477_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/jnci\/dji141","volume":"97","author":"D Thompson","year":"2005","unstructured":"Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, Taylor M, Easton DF (2005) Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 97:813\u2013822. https:\/\/doi.org\/10.1093\/jnci\/dji141","journal-title":"J Natl Cancer Inst"},{"key":"477_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/gepi.21971","volume":"40","author":"M Marabelli","year":"2016","unstructured":"Marabelli M, Cheng SC, Parmigiani G (2016) Penetrance of ATM gene mutations in breast cancer: A Meta-Analysis of different measures of risk. Genet Epidemiol 40:425\u2013431. https:\/\/doi.org\/10.1002\/gepi.21971","journal-title":"Genet Epidemiol"},{"key":"477_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5306\/wjco.v14.i2.40","volume":"14","author":"EN Imyanitov","year":"2023","unstructured":"Imyanitov EN, Kuligina ES, Sokolenko AP, Suspitsin EN, Yanus GA, Iyevleva AG, Ivantsov AO, Aleksakhina SN (2023) Hereditary cancer syndromes. World J Clin Oncol 14:40\u201368. https:\/\/doi.org\/10.5306\/wjco.v14.i2.40","journal-title":"World J Clin Oncol"},{"key":"477_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/ng.2224","volume":"44","author":"C Loveday","year":"2012","unstructured":"Loveday C, Turnbull C, Ruark E, Xicola RM, Ramsay E, Hughes D, Warren-Perry M, Snape K, Breast Cancer Susceptibility Collaboration (UK), Eccles D et al (2012) Germline RAD51C mutations confer susceptibility to ovarian cancer. Nat Genet 44:475\u2013476. https:\/\/doi.org\/10.1038\/ng.2224","journal-title":"Nat Genet"},{"key":"477_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P, Olson JE, Godwin AK, Pankratz VS, Olswold C et al (2015) Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 33:304\u2013311. https:\/\/doi.org\/10.1200\/JCO.2014.57.1414","journal-title":"J Clin Oncol"},{"key":"477_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13048-020-00654-3","volume":"13","author":"M Suszynska","year":"2020","unstructured":"Suszynska M, Ratajska M, Kozlowski P (2020) BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~\u200930,000 cases. J Ovarian Res 13:50. https:\/\/doi.org\/10.1186\/s13048-020-00654-3","journal-title":"J Ovarian Res"},{"key":"477_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41525-021-00203-x","volume":"6","author":"Q Xiao","year":"2021","unstructured":"Xiao Q, Lauschke VM (2021) The prevalence, genetic complexity and population-specific founder effects of human autosomal recessive disorders. NPJ Genom Med 6:41. https:\/\/doi.org\/10.1038\/s41525-021-00203-x","journal-title":"NPJ Genom Med"},{"key":"477_CR17","doi-asserted-by":"publisher","first-page":"9335","DOI":"10.3390\/ijms25179335","volume":"25","author":"GA Yanus","year":"2024","unstructured":"Yanus GA, Suspitsin EN, Imyanitov EN (2024) The spectrum of Disease-Associated alleles in countries with a predominantly Slavic population. Int J Mol Sci 25:9335. https:\/\/doi.org\/10.3390\/ijms25179335","journal-title":"Int J Mol Sci"},{"key":"477_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10689-022-00296-y","volume":"22","author":"GA Yanus","year":"2023","unstructured":"Yanus GA, Savonevich EL, Sokolenko AP, Romanko AA, Ni VI, Bakaeva EK, Gorustovich OA, Bizin IV, Imyanitov EN (2023) Founder vs. non-founder BRCA1\/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations. Fam Cancer 22:19\u201330. https:\/\/doi.org\/10.1007\/s10689-022-00296-y","journal-title":"Fam Cancer"},{"key":"477_CR19","unstructured":"2021 Russian Census (2021) https:\/\/rosstat.gov.ru\/vpn\/2020\/Tom5_Nacionalnyj_sostav_i_vladenie_yazykami. Assessed 13 January 2025."},{"key":"477_CR20","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R, Massouras A (2019) VarSome: the human genomic variant. Search Engine Bioinf 35:1978\u20131980. https:\/\/doi.org\/10.1093\/bioinformatics\/bty897","journal-title":"Search Engine Bioinf"},{"key":"477_CR21","unstructured":"Golden Helix GenomeBrowse \u00ae visualization tool (Version 2.x) [Software]. Bozeman, MT: Golden Helix, Inc. http:\/\/www.goldenhelix.com. Assessed 10 January 2025"},{"key":"477_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10549-020-05827-8","volume":"184","author":"AP Sokolenko","year":"2020","unstructured":"Sokolenko AP, Sokolova TN, Ni VI, Preobrazhenskaya EV, Iyevleva AG, Aleksakhina SN, Romanko AA, Bessonov AA, Gorodnova TV, Anisimova EI et al (2020) Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients. Breast Cancer Res Treat 184:229\u2013235. https:\/\/doi.org\/10.1007\/s10549-020-05827-8","journal-title":"Breast Cancer Res Treat"},{"key":"477_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fonc.2018.00421","volume":"8","author":"OI Brovkina","year":"2018","unstructured":"Brovkina OI, Shigapova L, Chudakova DA, Gordiev MG, Enikeev RF, Druzhkov MO, Khodyrev DS, Shagimardanova EI, Nikitin AG, Gusev OA (2018) The Ethnic-Specific spectrum of germline nucleotide variants in DNA damage response and repair genes in hereditary breast and ovarian Cancer patients of Tatar descent. Front Oncol 8:421. https:\/\/doi.org\/10.3389\/fonc.2018.00421","journal-title":"Front Oncol"},{"key":"477_CR24","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/s12885-019-5765-3","volume":"19","author":"WM Cao","year":"2019","unstructured":"Cao WM, Zheng YB, Gao Y, Ding XW, Sun Y, Huang Y, Lou CJ, Pan ZW, Peng G, Wang XJ (2019) Comprehensive mutation detection of BRCA1\/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women. BMC Cancer 19:551. https:\/\/doi.org\/10.1186\/s12885-019-5765-3","journal-title":"BMC Cancer"},{"key":"477_CR25","first-page":"507","volume":"17","author":"FS Akhatova","year":"2013","unstructured":"Akhatova FS, Rizvanova FF, Khusnutdinova EK (2013) Y-Chromosome haplotypes in the populations of Tatar in Russia. Middle-East J Sci Res 17:507\u2013509","journal-title":"Middle-East J Sci Res"},{"key":"477_CR26","first-page":"75","volume":"3","author":"EV Balanovska","year":"2016","unstructured":"Balanovska EV, Agdzhoyan AT, Zhabagin MK, Yusupov YM, Skhalyakho RA, Dolinina DO, Padyukova AD, Kuznetsova MA, Markina NV, Atramentova LA, Lavryashina MB, Balanovsky OP (2016) The Tatars of Eurasia: peculiarity of Crimean, Volga and Siberian Tatar gene pools. Lomonosov J Anthropol 3:75\u201385 [In Russian]","journal-title":"Lomonosov J Anthropol"},{"key":"477_CR27","doi-asserted-by":"publisher","first-page":"e0135820","DOI":"10.1371\/journal.pone.0135820","volume":"10","author":"A Kushniarevich","year":"2015","unstructured":"Kushniarevich A, Utevska O, Chuhryaeva M, Agdzhoyan A, Dibirova K, Uktveryte I, M\u00f6ls M, Mulahasanovic L, Pshenichnov A, Frolova S et al (2015) Genetic heritage of the Balto-Slavic speaking populations: A synthesis of autosomal, mitochondrial and Y-Chromosomal data. PLoS ONE 10:e0135820. https:\/\/doi.org\/10.1371\/journal.pone.0135820","journal-title":"PLoS ONE"},{"key":"477_CR28","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, Maglott DR (2014) ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 42:D980\u2013D985. https:\/\/doi.org\/10.1093\/nar\/gkt1113","journal-title":"Nucleic Acids Res"},{"key":"477_CR29","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1001\/jamaoncol.2017.1996","volume":"3","author":"T Walsh","year":"2017","unstructured":"Walsh T, Mandell JB, Norquist BM, Casadei S, Gulsuner S, Lee MK, King MC (2017) Genetic predisposition to breast Cancer due to mutations other than BRCA1 and BRCA2 founder alleles among Ashkenazi Jewish women. JAMA Oncol 3:1647\u20131653. https:\/\/doi.org\/10.1001\/jamaoncol.2017.1996","journal-title":"JAMA Oncol"},{"key":"477_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ajhg.2018.07.002","volume":"103","author":"DGR Evans","year":"2018","unstructured":"Evans DGR, van Veen EM, Byers HJ, Wallace AJ, Ellingford JM, Beaman G, Santoyo-Lopez J, Aitman TJ, Eccles DM, Lalloo FI, Smith MJ, Newman WG (2018) A dominantly inherited 5\u2019 UTR variant causing Methylation-Associated Silencing of BRCA1 as a cause of breast and ovarian Cancer. Am J Hum Genet 103:213\u2013220. https:\/\/doi.org\/10.1016\/j.ajhg.2018.07.002","journal-title":"Am J Hum Genet"},{"key":"477_CR31","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1373\/clinchem.2008.120931","volume":"55","author":"KM de Vooght","year":"2009","unstructured":"de Vooght KM, van Wijk R, van Solinge WW (2009) Management of gene promoter mutations in molecular diagnostics. Clin Chem 55:698\u2013708. https:\/\/doi.org\/10.1373\/clinchem.2008.120931","journal-title":"Clin Chem"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00477-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00477-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00477-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:57:38Z","timestamp":1750899458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00477-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00477-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6183856\/v1","asserted-by":"object"}]},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"8 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of the N.N. Petrov National Medicine Research Center of Oncology and conducted in accordance with the Declaration of Helsinki protocol. All patients gave informed consent for the collection and use of their data for a scientific purpose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"50"}}